vaccine and vaccine adjuvant development

Combined Therapeutics (CTx) is a privately held biotechnology company developing next-generation high-value mRNA vaccines to protect against global infectious diseases and to treat cancer. Its proprietary MOP CTx platform combines Multi Organ Protective binding miRNA sequences with therapeutic mRNAs in lipid nanoparticles to target protein expression to specific tissues while reducing off-target effects and protecting vital organs such as the heart, liver, and kidneys.

Read more

mRNA platform developmenttissue-specific mRNA expression targeting